5-PYRIMIDINECARBOXAMIDE, 2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)-
Idiopathic Interstitial Pneumonias
CelgeneSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Idiopathic Interstitial Pneumonias cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
BARDOXOLONE METHYL ESTER Biogen | Phase 2 | B |
FAPi-46 University of California, Los Angeles | Early Phase 1 | C |
Same molecule, other indications
5-PYRIMIDINECARBOXAMIDE, 2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →